Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Burak Kulaksızoğlu, Hüseyin Kara, Berkan Bodur & Murat Kuloğlu. (2018) Intravenous buprenorphine/naloxone and concomitant oral pregabalin misuse: a case report. Neuropsychiatric Disease and Treatment 14, pages 3033-3035.
Read now
Read now
Elena P. Calandre, Fernando Rico-Villademoros & Mahmoud Slim. (2016) Alpha2delta ligands, gabapentin, pregabalin and mirogabalin: a review of their clinical pharmacology and therapeutic use. Expert Review of Neurotherapeutics 16:11, pages 1263-1277.
Read now
Read now
Kinga Sałat, Jadwiga Witalis, Monika Zadrożna, Zbigniew Sołtys, Barbara Nowak, Barbara Filipek, Krzysztof Więckowski & Barbara Malawska. (2015) 3-[4-(3-Trifluoromethyl-phenyl)-piperazin-1-yl]-dihydrofuran-2-one and pregabalin attenuate tactile allodynia in the mouse model of chronic constriction injury. Toxicology Mechanisms and Methods 25:7, pages 514-523.
Read now
Read now
Mark S. Juhn, Bruce Parsons, Roxanna Varvara & Alesia Sadosky. (2015) Pregabalin for painful diabetic peripheral neuropathy: strategies for dosing, monotherapy vs. combination therapy, treatment-refractory patients, and adverse events. Current Medical Research and Opinion 31:5, pages 1017-1026.
Read now
Read now
Jan Schjøtt & Jenny Bergman. (2014) Joint medicine-information and pharmacovigilance services could improve detection and communication about drug-safety problems. Drug, Healthcare and Patient Safety 6, pages 89-92.
Read now
Read now
Joseph Chukwu, Norman Delanty, David Webb & Gianpiero L Cavalleri. (2014) Weight change, genetics and antiepileptic drugs. Expert Review of Clinical Pharmacology 7:1, pages 43-51.
Read now
Read now
Kinga Sałat, Tadeusz Librowski, Barbara Nawiesniak & Monika Gluch-Lutwin. (2013) Evaluation of analgesic, antioxidant, cytotoxic and metabolic effects of pregabalin for the use in neuropathic pain. Neurological Research 35:9, pages 948-958.
Read now
Read now
Articles from other publishers (13)
Helin Xie, You Zheng, Chenyu Wang, Shiwei Song, Yihai Dai, Xian Huang, Maobai Liu & Xuemei Wu. (2023) Managing delayed or missed pregabalin doses in patients with focal epilepsy: a Monte Carlo simulation study. International Journal of Clinical Pharmacy.
Crossref
Crossref
Verónica Salazar. 2022. Canine and Feline Anesthesia and Co‐Existing Disease. Canine and Feline Anesthesia and Co‐Existing Disease
502
565
.
Tara GomesSimon GreavesWim van den BrinkTony AntoniouMuhammad M. MamdaniJ. Michael PatersonDiana MartinsDavid N. Juurlink. (2018) Pregabalin and the Risk for Opioid-Related Death: A Nested Case–Control Study. Annals of Internal Medicine 169:10, pages 732.
Crossref
Crossref
Julie H. Ishida, Charles E. McCulloch, Michael A. Steinman, Barbara A. Grimes & Kirsten L. Johansen. (2018) Gabapentin and Pregabalin Use and Association with Adverse Outcomes among Hemodialysis Patients. Journal of the American Society of Nephrology 29:7, pages 1970-1978.
Crossref
Crossref
Mihir ParekhGopal Krishna DashIsthiaque Ahamed. (2017) Pregabalin Toxicity Manifesting as Reversible Encephalopathy With Continuous Triphasic Waves in Electroencephalogram. Clinical Neuropharmacology 40:5, pages 226-228.
Crossref
Crossref
Stefania Chiappini & Fabrizio Schifano. (2016) A Decade of Gabapentinoid Misuse: An Analysis of the European Medicines Agency’s ‘Suspected Adverse Drug Reactions’ Database. CNS Drugs 30:7, pages 647-654.
Crossref
Crossref
Rainer Freynhagen, Michael Serpell, Birol Emir, Ed Whalen, Bruce Parsons, Andrew Clair & Mark Latymer. (2013) A Comprehensive Drug Safety Evaluation of Pregabalin in Peripheral Neuropathic Pain. Pain Practice 15:1, pages 47-57.
Crossref
Crossref
Veronica Salazar. 2014. Canine and Feline Anesthesia and Co-Existing Disease. Canine and Feline Anesthesia and Co-Existing Disease
264
298
.
Cory Toth. (2013) Pregabalin: latest safety evidence and clinical implications for the management of neuropathic pain. Therapeutic Advances in Drug Safety 5:1, pages 38-56.
Crossref
Crossref
W. Lau, C. Dykstra, S. Thevarkunnel, L.B. Silenieks, I.A.M. de Lannoy, D.K.H. Lee & G.A. Higgins. (2013) A back translation of pregabalin and carbamazepine against evoked and non-evoked endpoints in the rat spared nerve injury model of neuropathic pain. Neuropharmacology 73, pages 204-215.
Crossref
Crossref
Robert Sałat & Kinga Sałat. (2013) The application of support vector regression for prediction of the antiallodynic effect of drug combinations in the mouse model of streptozocin-induced diabetic neuropathy. Computer Methods and Programs in Biomedicine 111:2, pages 330-337.
Crossref
Crossref
Maximilian Gahr, Roland. W. Freudenmann, Christoph Hiemke, Makus A. Kölle & Carlos Schönfeldt-Lecuona. (2013) Pregabalin abuse and dependence in Germany: results from a database query. European Journal of Clinical Pharmacology 69:6, pages 1335-1342.
Crossref
Crossref
Daniele Tomassoni, Francesco Amenta, Lorenzo Di Cesare Mannelli, Carla Ghelardini, Innocent E. Nwankwo, Alessandra Pacini & Seyed Khosrow Tayebati. (2013) Neuroprotective Activity of Thioctic Acid in Central Nervous System Lesions Consequent to Peripheral Nerve Injury. BioMed Research International 2013, pages 1-14.
Crossref
Crossref